Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/05/1989 | US4863964 Method for the stabilization of deferoxamine to chelate free ions in physiological fluid |
09/05/1989 | US4863963 Novel cinnamoylamide derivatives |
09/05/1989 | US4863962 D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease |
09/05/1989 | US4863958 Treating allergic conditions, asthma, cardiovascular disorders, and inflammation |
09/05/1989 | US4863957 Anticholesterol agents |
09/05/1989 | US4863956 Process for obtaining proanthocyanidine A2, pharmaceutical compositions and their therapeutic use |
09/05/1989 | US4863955 Scytophycins |
09/05/1989 | US4863953 [3R]-3-amino-1-hydroxy pyrrolidin-2-one and its use as a neuroprotective agent |
09/05/1989 | US4863951 Pharmacologically active amino-5,6,7,8-tetrahydronaphtho [2,3-B] furan compounds |
09/05/1989 | US4863949 Aminopropanol derivatives, processes for the preparation thereof, the use thereof and pharmaceutical compositions containing them |
09/05/1989 | US4863948 Isoindolinone sulfonamide anti-arrhythmic agents |
09/05/1989 | US4863946 Hypoglycemic and hypotensive agents |
09/05/1989 | US4863945 Pyrrolobenzimidazoles and pharmaceutical compositions containing them |
09/05/1989 | US4863941 Platelet activating factor inhibitors, antitumor agents |
09/05/1989 | US4863939 Heteroarylethylamine as production promoters in livestock |
09/05/1989 | US4863938 Pyridine derivatives and their use as nootropic agents |
09/05/1989 | US4863935 Mitomycin compounds having useful anti-tumor activity |
09/05/1989 | US4863933 3-hydroxypyridines |
09/05/1989 | US4863932 Squalene oxide cyclase inhibitors and therapeutic use thereof |
09/05/1989 | US4863931 Antihistaminic fluoro substituted benzocycloheptapyridines |
09/05/1989 | US4863930 Choleretic agent, cognition activator |
09/05/1989 | US4863929 12- and 13-substituted ergoline derivatives having alpha2 -receptor-blocking effect |
09/05/1989 | US4863928 Method of treatment for arthritic and inflammatory diseases |
09/05/1989 | US4863927 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils |
09/05/1989 | US4863926 Anticoagulants, hypotensive agents |
09/05/1989 | US4863925 Substituted |
09/05/1989 | US4863924 N-benzoyl urea compounds, antitumorous compositions containing them |
09/05/1989 | US4863923 Method of inhibiting superoxide release |
09/05/1989 | US4863922 Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use |
09/05/1989 | US4863921 Gastrointestinal disorders |
09/05/1989 | US4863919 Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes |
09/05/1989 | US4863916 Substituted 6-hydroxymethyl-carbapenem antibiotics |
09/05/1989 | US4863915 β-lactam antibiotics |
09/05/1989 | US4863914 Bactericides, antibiotics |
09/05/1989 | US4863912 Use of tetrahydrocortisol in glaucoma therapy |
09/05/1989 | US4863911 Method for treating male sexual dysfunction |
09/05/1989 | US4863908 Mono(2-ammonium-2-hydroxymethyl-1,3 propanediol)(2R-cis)-3-methyloxiranyl)phosphonate, its preparation and pharmaceutical compositions containing it |
09/05/1989 | US4863906 2'-deoxy-5-ethynyluridine-3',5'-diestens for treatment of VZV and CMV infections |
09/05/1989 | US4863898 Amino acid chelated compositions for delivery to specific biological tissue sites |
09/05/1989 | US4863748 Dietary products and uses comprising methylsulfonylmethane |
09/05/1989 | US4863742 Controlled absorption pharmaceutical composition |
09/05/1989 | US4863739 Antitumor agents |
09/05/1989 | US4863738 Transdermal drug delivery |
09/05/1989 | US4863737 Transmucosal delivery |
09/05/1989 | US4863724 Anti-diabetic pharmaceutical compositions and the preparation thereof |
09/05/1989 | US4863720 Pharmaceutical preparation and methods for its production |
09/05/1989 | CA1259073A1 Fused furanones, processes for their preparation and their use in medicaments |
09/05/1989 | CA1259072A1 PROCESS FOR PREPARING .alpha.-HYDROXYLATED CHAIN 2- SUBSTITUTED 4-HYDROXY-3-QUINOLINE CARBOXYLIC ACID ESTER DERIVATIVES |
09/05/1989 | CA1259071A1 Process for the preparation of optically-active carbazole derivatives, r- and s-carbazole derivatives and pharmaceutical compositions containing these compounds |
09/05/1989 | CA1259070A1 Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles |
09/05/1989 | CA1259045A1 Membrane polysaccharides useful as drugs and preparation process thereof |
08/31/1989 | DE3804858A1 Remedy for hyperuricaemia |
08/30/1989 | EP0330629A2 Guanidine derivatives having hypotensive activity, composition containing them, and process for obtaining them |
08/30/1989 | EP0330625A2 Total synthesis method for making an indole structure derivative product class, of the triptamine type, in particular, melatonin or N-acetyl-5-methoxytriptamine type, having a high purity degree and easily soluble, for therapeutic use against acquired immuno-deficiency syndromes |
08/30/1989 | EP0330583A2 Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application |
08/30/1989 | EP0330532A1 New galenic form of fenofibrate |
08/30/1989 | EP0330511A2 Stabilization of 13,14-dihydro-15-ketoprostaglandins |
08/30/1989 | EP0330496A2 Skin treatment composition |
08/30/1989 | EP0330485A1 4-Amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion |
08/30/1989 | EP0330469A2 Tetrahydroisoquinoline derivatives |
08/30/1989 | EP0330468A2 Use of heterocyclic derivatives as kappa-opioid receptor agonists in the treatment of cerebral ischaemia |
08/30/1989 | EP0330467A1 Heterocyclic compounds |
08/30/1989 | EP0330461A2 Piperidine derivatives |
08/30/1989 | EP0330444A2 Novel thiorhodamines and a novel method of preparation |
08/30/1989 | EP0330432A1 Improvements relating to the control of neoplastic tissue growth |
08/30/1989 | EP0330380A2 Novel indanoxyacetic acid derivatives and processes for preparing the same |
08/30/1989 | EP0330360A1 1,2,3,4-Tetrahydroisoquinolines, processes for their preparation, and their use as kappa-receptor agonists |
08/30/1989 | EP0330358A2 Method of identifying whole cells having serine esterase activity |
08/30/1989 | EP0330353A1 Tetrazole excitatory amino acid receptor antagonists |
08/30/1989 | EP0330340A1 Therapeutic agents |
08/30/1989 | EP0330329A1 Antiulcer pyrimidine derivatives |
08/30/1989 | EP0330327A2 Dihydropyridines, their preparation and their use as PAF-antagonists |
08/30/1989 | EP0330283A1 Novel 5,6-diphenyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives |
08/30/1989 | EP0330263A1 Piperazinylalkylpyrimidines as hypoglycemic agents |
08/30/1989 | EP0330242A1 Pyridazinone derivatives, their preparation and use |
08/30/1989 | EP0330218A2 Inhibitors of lysyl oxidase |
08/30/1989 | EP0330172A2 Improved process for trans-6-[2-(substituted-pyrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
08/30/1989 | EP0330108A1 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds |
08/30/1989 | EP0330065A1 Sulfonamide compounds |
08/30/1989 | EP0330057A2 Substituted pyrimidines |
08/30/1989 | EP0330052A2 Use of benzimidazoles for preparing a medicine with an anti-ischemial activity on the heart, and combinations with betablockers or bradycardics |
08/30/1989 | EP0330047A2 Method for the sterilization of blood, plasma, blood derivatives, plasma derivatives, cell suspensions or the like |
08/30/1989 | EP0330041A2 Substituted 1,2,4-trazine diones, process for their synthesis and their use |
08/30/1989 | EP0330031A1 Therapeutic agents for the treatment of peptic ulcer disease |
08/30/1989 | EP0330026A1 Piperidinoalkyl derivatives of carboxylic acid amides |
08/30/1989 | EP0330025A2 Antidiabetic composition comprising isocarbacyclin derivative |
08/30/1989 | EP0330017A2 Use of thiazoles for increasing animal performance |
08/30/1989 | EP0329948A2 Use of beta-adrenergic blocking agents in the treatment of the progression of infantile myopia |
08/30/1989 | EP0329940A1 5-(substituted)amino)-8- (phenyl or substituted phenyl)-3H,6H-1,2,5,a,8 a-tetraazaacenaphthylen-3-ones |
08/30/1989 | EP0329932A2 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments |
08/30/1989 | EP0329905A1 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility |
08/30/1989 | EP0329904A1 Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety |
08/30/1989 | EP0329903A1 Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma |
08/30/1989 | EP0329902A1 Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis |
08/30/1989 | EP0329900A1 Substituted 1-aralkyl imidazoline-2-thiols |
08/30/1989 | EP0329879A1 Amino acids useful in hepatic disorders |
08/30/1989 | EP0329785A1 Cephalosporin derivatives |
08/30/1989 | EP0329737A1 Tri-aza macrocycles and metal complexes thereof |
08/30/1989 | EP0329711A1 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane compounds |
08/30/1989 | EP0329708A1 Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid. |